tiprankstipranks
ALK-abello A/S Class B (AKBLF)
:AKBLF
US Market

ALK-abello (AKBLF) Earnings Dates, Call Summary & Reports

Compare
9 Followers

Earnings Data

Report Date
May 06, 2025
TBA Not Confirmed
Period Ending
2025 (Q1)
Consensus EPS Forecast
0.2
Last Year’s EPS
0.15
Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Feb 19, 2025
|
% Change Since: -4.06%
|
Next Earnings Date:May 06, 2025
Earnings Call Sentiment|Neutral
The earnings call presented a strong year for ALK with record revenue growth and positive execution of strategic initiatives, particularly in Europe. However, challenges in North America and international markets, especially China, alongside negative free cash flow, reflect areas of concern.
Company Guidance
In the call discussing ALK's fiscal year 2024 results and 2025 outlook, several key metrics were highlighted. For 2024, ALK reported a 15% revenue increase, reaching over DKK5.5 billion, driven primarily by European tablet sales, which grew by 31%. The company's EBIT exceeded DKK1 billion for the first time, marking a 65% improvement in local currencies. The operating profit margin increased from 14% to 20%, and the underlying EBIT margin would have surpassed 21% without one-off costs. Despite these achievements, free cash flow was negative at minus DKK204 million, largely due to a DKK1 billion upfront payment for the Neffy strategic license deal. For 2025, ALK projects revenue growth of 9% to 13%, with an EBIT margin increase to around 25%. Key growth drivers include double-digit tablet sales growth across all regions, especially with anticipated contributions from the launch of the children's house dust mite tablet in Europe and North America.
Record Revenue Growth
2024 was a record year for ALK with revenue up 15%, driven primarily by European tablet sales. Earnings improved by 65% in local currencies, and the EBIT result exceeded DKK1 billion for the first time.
European Market Performance
Europe stood out as an exceptional contributor to growth, with sales up 22% and European tablet sales increasing by 31%. ALK consolidated its position as the European market leader.
Successful Execution of Allergy+ Strategy
The Allergy+ strategy started delivering desired results, expanding addressable market in respiratory allergy, and building new revenue streams in the broader allergy space.
Neffy Nasal Spray Launch
ALK entered the largest in-licensing deal in its history with the rights for Neffy, a nasal spray for emergency treatment. Launch preparations are underway, with expectations to contribute to growth from the second half of the year.
Sustainability and Optimization Initiatives
ALK implemented optimization initiatives generating savings of more than DKK300 million in '25, exceeding the original target of DKK250 million.
---

ALK-abello (AKBLF) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

AKBLF Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 06, 20252025 (Q1)
0.20 / -
0.155
Feb 19, 20252024 (Q4)
0.13 / 0.11
0.09420.30% (+0.02)
Nov 14, 20242024 (Q3)
0.11 / 0.14
0.07100.00% (+0.07)
Aug 22, 20242024 (Q2)
0.10 / 0.13
0.042200.00% (+0.08)
May 02, 20242024 (Q1)
0.14 / 0.15
0.10349.66% (+0.05)
Feb 08, 20242023 (Q4)
0.11 / 0.09
0.042121.67% (+0.05)
Nov 15, 20232023 (Q3)
0.05 / 0.07
0.017306.50% (+0.05)
Aug 24, 20232023 (Q2)
0.04 / 0.04
0.02287.50% (+0.02)
May 09, 20232023 (Q1)
0.07 / 0.10
0.109-5.16% (>-0.01)
Feb 03, 20232022 (Q4)
0.04 / 0.04
0.047-10.18% (>-0.01)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

AKBLF Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 19, 2025$21.66$22.82+5.36%
Nov 14, 2024$22.88$22.60-1.22%
Aug 22, 2024$23.95$24.12+0.71%
May 02, 2024$18.68$18.58-0.54%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does ALK-abello A/S Class B (AKBLF) report earnings?
ALK-abello A/S Class B (AKBLF) is schdueled to report earning on May 06, 2025, TBA Not Confirmed.
    What is ALK-abello A/S Class B (AKBLF) earnings time?
    ALK-abello A/S Class B (AKBLF) earnings time is at May 06, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is AKBLF EPS forecast?
          AKBLF EPS forecast for the fiscal quarter 2025 (Q1) is 0.2.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis